Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D1.326 - Six Cases of Adult-Onset PFAPA (Periodic Fever, Aphthous stomatitis, Pharyngitis, and Cervical Adenopathy) Syndrome
D1.327 - A Rare Primary Immunodeficency Hidden in Autoimmunity: Heterozygote CD3G variant in a 49-year-old Female Patient
D1.332 - Hereditary Angioedema in Ukraine
D1.333 - A Newly Identified POLE1 Deficiency (FILS Syndrome) Patient with Severe Immunodeficiency: Clinical Course and Treatment Approach
D1.334 - A Novel Variant in ALPS Type V Due to CTLA-4 Deficiency: A Case Presenting with Cytopenia
D1.335 - TeloNet is born; why immunologists should know about telomere disorders
D1.336 - Sirolimus for the treatment of the Immunodeficiency Linked to PIK3CD (APDS1)
D1.337 - Clinical features of patients submitted to immunoglobulin replacement therapy in an outpatient regimen at a tertiary hospital during 2024
- D3.24 - From angioedema to Kimura disease: Diagnostic challenge
- D3.27 - Chlorhexidine as a Hidden Everyday Allergen
D3.17 - Systemic Histaminergic Findings in Children with Chronic Urticaria
D3.18 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
D3.19 - Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years
D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media
D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
D3.23 - Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre
D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis
D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
D3.29 - Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients
D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download